| S. No | Title | Location | References |
| 1 | Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia | France | https://clinicaltrials.gov/ct2/show/NCT04334850 |
| 2 | Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early | Greece | https://clinicaltrials.gov/ct2/show/NCT04398004 |
| 3 | A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic | Austria | https://clinicaltrials.gov/ct2/show/NCT04369365 |
| 4 | Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection | United States | https://clinicaltrials.gov/ct2/show/NCT04341727 |
| 5 | Azithromycin for COVID-19 Treatment in Outpatients Nationwide | United States | https://clinicaltrials.gov/ct2/show/NCT04332107 |
| 6 | Ivermectin Adjuvant to Hydroxychloroquin and Azithromycine in COVID19 Patients | Iraq | https://clinicaltrials.gov/ct2/show/NCT04343092 |
| 7 | Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients | France | https://clinicaltrials.gov/ct2/show/NCT04341207 |
| 8 | Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to “no Treatment” in SARS CoV 2 Virus | Israel | https://clinicaltrials.gov/ct2/show/NCT04355052 |
| 9 | Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19 | Mexico | https://clinicaltrials.gov/ct2/show/NCT04399746 |
| 10 | Novel Agents for Treatment of High-risk COVID-19 Positive Patients | United States | https://clinicaltrials.gov/ct2/show/NCT04374019 |
| 11 | Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 | United States | https://clinicaltrials.gov/ct2/show/NCT04329832 |
| 12 | Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection | United States | https://clinicaltrials.gov/ct2/show/NCT04339426 |
| 13 | Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 | United States | https://clinicaltrials.gov/ct2/show/NCT04334382 |
| 14 | Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease | United States | https://clinicaltrials.gov/ct2/show/NCT04344444 |
| 15 | Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 | Spain | https://clinicaltrials.gov/ct2/show/NCT04332094 |
| 16 | Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting | United States | https://clinicaltrials.gov/ct2/show/NCT04370782 |
| 17 | Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 | United States | https://clinicaltrials.gov/ct2/show/NCT04358068 |
| 18 | Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19 | United States | https://clinicaltrials.gov/ct2/show/NCT04336332 |
| 19 | Treatment for COVID-19 in High-Risk Adult Outpatients | United States | https://clinicaltrials.gov/ct2/show/NCT04354428 |
| 20 | Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 | United States | https://clinicaltrials.gov/ct2/show/NCT04344457 |
| 21 | Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection | United States | https://clinicaltrials.gov/ct2/show/NCT04335552 |
| 22 | Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora | Italy | https://clinicaltrials.gov/ct2/show/NCT04366089 |
| 23 | Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus | France | https://clinicaltrials.gov/ct2/show/NCT04344379 |
| 24 | Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 | Denmark | https://clinicaltrials.gov/ct2/show/NCT04322396 |
| 25 | Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) | France | https://clinicaltrials.gov/ct2/show/NCT04345861 |
| 26 | Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) | Brazil | https://clinicaltrials.gov/ct2/show/NCT04321278 |
| 27 | Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial | Canada | https://clinicaltrials.gov/ct2/show/NCT04324463 |
